Quince Therapeutics, Inc.

QNCX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$6,452$16,826$7,771$6,212
Short-Term Investments$19,836$17,882$23,828$34,572
Receivables$0$992$916$882
Inventory$0$0$0$0
Other Curr. Assets$2,914$1,645$1,314$2,370
Total Curr. Assets$29,202$37,345$33,829$44,036
Property Plant & Equip (Net)$1,097$1,080$941$813
Goodwill$0$0$0$0
Intangibles$67,726$67,566$62,362$60,045
Long-Term Investments$78$78$78$78
Tax Assets$0$0$0$0
Other NC Assets$11,796$11,141$9,876$9,506
Total NC Assets$80,697$79,865$73,257$70,442
Other Assets$0$0$3$0
Total Assets$109,899$117,210$107,089$114,478
Liabilities
Payables$3,403$1,759$3,008$2,903
Short-Term Debt$17,634$112$102$96
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,007$5,596$5,246$4,279
Total Curr. Liab.$26,044$7,467$8,356$7,278
LT Debt$359$17,376$15,649$14,715
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$5,593$5,595$5,172$4,963
Other NC Liab.$76,844$75,036$59,331$57,376
Total NC Liab.$82,796$98,007$80,152$77,054
Other Liabilities$0$0$0$0
Cap. Leases$359$499$485$490
Total Liabilities$108,840$105,474$88,508$84,332
Equity
Pref Stock$0$0$0$0
Common Stock$54$53$44$44
Retained Earnings-$420,993-$407,551-$391,502-$376,472
AOCI$6,293$6,156$1,957-$35
Other Equity$415,705$413,078$408,082$406,609
Total Equity$1,059$11,736$18,581$30,146
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$109,899$117,210$107,089$114,478
Net Debt$11,541$662$7,980$8,599